Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06181513
Status:
RECRUITING
Last Update Posted:
2023-12-26
First Post:
2023-12-08
Brief Title:
Probiotics in Mild Alzheimers Disease
Sponsor:
University of Nicosia
Organization:
University of Nicosia
Study Overview
Official Title:
Effect of Probiotics on Cognitive Functioning of Patients With Mild Alzheimers Disease
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main objective is to investigate whether administration of probiotics to patients with mild Alzheimers Disease AD reduces neuroinflammation improves cognitive function and modifies neurophysiological measures compared to a patient group that receives placebo no active probiotics
Detailed Description:
We will measure specific blood inflammatory markers primary outcome neurophysiological activity cognitive test scores microbiome composition and dietary habits of participants in the probiotics and placebo group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None